Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Discover Oncology · 11.08.2024 · 15 (1)
DOI: 10.1007/s12672-024-01195-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Discover Oncology, online erschienen am 11.08.2024. Verfasst von Deepak Chandra Joshi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandar Sindri, Dist., Ajmer, Rajasthan, India. Dee…. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 281 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Novel therapeutic agents in clinical trials offer a paradigm shift in the approach to battling this prevalent and destructive disease, and the area of cancer therapy is on the precipice of a trans formative revolution. Despite the importance of tried-and-true cancer treatments like surgery, radiation, and chemotherapy, the disease continues to evolve and adapt, making new, more potent methods necessary. The field of cancer therapy is currently witnessing the emergence of a wide range of innovative approaches. Immunotherapy, including checkpoint inhibitors, CAR-T cell treatment, and cancer vaccines, utilizes the host’s immune system to selectively target and eradicate malignant cells while minimizing harm to normal tissue. The development of targeted medicines like kinase inhibitors and monoclonal antibodies has allowed for more targeted and less harmful approaches to treating cancer. With the help of genomics and molecular profiling, “precision medicine” customizes therapies to each patient’s unique genetic makeup to maximize therapeutic efficacy while minimizing unwanted side effects. Epigenetic therapies, metabolic interventions, radio-pharmaceuticals, and an increasing emphasis on combination therapy with synergistic effects further broaden the therapeutic landscape. Multiple-stage clinical trials are essential for determining the safety and efficacy of these novel drugs, allowing patients to gain access to novel treatments while also furthering scientific understanding. The future of cancer therapy is rife with promise, as the integration of artificial intelligence and big data has the potential to revolutionize early detection and prevention. Collaboration among researchers, and healthcare providers, and the active involvement of patients remain the bedrock of the ongoing battle against cancer. In conclusion, the dynamic and evolving landscape of cancer therapy provides hope for improved treatment outcomes, emphasizing a patient-centered, data-driven, and ethically grounded approach as we collectively strive towards a cancer-free world.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandar Sindri, Dist., Ajmer, Rajasthan, India. Deepakjoshi024@gmail.com.
- Invertis Institute of Pharmacy, Invertis University Bareilly Uttar Pradesh, Bareilly, India.
- Chandigarh University, Ludhiana-Chandigarh State Highway, Gharuan, Mohali, Punjab, 140413, India.
- Institute of Pharmaceutical Sciences, Faculty of Engineering and Technology, University of Lucknow, Lucknow, India.
- Himalayan Institute of Pharmacy, Road, Near Suketi Fossil Park, Kala Amb, Hamidpur, Himachal Pradesh, India.
- Meerut Institute of Technology, Meerut, Uttar Pradesh, India.
Zitieren
APA
Joshi, D. C., Sharma, A., Prasad, S., Singh, K., Kumar, M., Sherawat, K., Tuli, H. S., & Gupta, M. (2024). Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy. Discover Oncology, 15(1). https://doi.org/10.1007/s12672-024-01195-7
Vancouver
Joshi DC, Sharma A, Prasad S, Singh K, Kumar M, Sherawat K, et al. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy. Discover Oncology. 2024;15(1). doi:10.1007/s12672-024-01195-7
BibTeX
@article{Joshi2024,
author = {Joshi, Deepak Chandra and Sharma, Anurag and Prasad, Sonima and Singh, Karishma and Kumar, Mayank and Sherawat, Kajal and Tuli, Hardeep Singh and Gupta, Madhu},
title = {Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy},
journal = {Discover Oncology},
year = {2024},
volume = {15},
number = {1},
doi = {10.1007/s12672-024-01195-7}
}
EUVIMED